Based on the input of experts and nonprofit leaders, our white paper describes challenges in five policy areas and provides a set of policy options for policymakers to consider which could improve the sustainability of the nonprofit model and help to reduce the burden of high prescription drug prices.
Etelle Higonnet, senior director at Waxman Strategies has been named a Chevalier of France’s Ordre national du Mérite (National Order of Merit) by French President Emmanuel Macron, recognizing her work to protect the environment.
In a blog post for Health Affairs, Chairman Henry Waxman debunks the age-old industry claim that lower drug costs mean a loss of drug innovation, noting they made the same unsubstantiated claim back in the 1980s during debate on the Hatch-Waxman Act.
In a piece written for Health Affairs this week, our Chairman Henry Waxman discusses the broken pharmaceutical marketplace, how empowering Medicare to negotiate prices with the pharmaceutical industry will make prescription drugs more affordable for everyone, and why we need the Lower Drug Costs Now Act.
In a piece written for Health Affairs this week, Health Practice Managing Director Kristi Martin joins Jonathan Foley of Westcott Partners and Rob Shriver of IdeaCrew to discuss the Affordable Care Act’s Multi-State Plan Program, lessons learned from its demise and how we can use those lessons to inform discussion on the public option.
This week, many of us here at Waxman Strategies packed our bags and temporarily relocated to New York City, where we were thrilled to host a reception as an official part of Climate Week NYC. The event, an evening of cocktails, hors d’oeuvres, and conversation, was held at Candle 79, an upscale restaurant with a plant-based menu.
Selecting and designing an office space is no easy feat. There’s a whole lot to consider, starting with how we create an environment that reinforces who we are and reflects our culture and values. Well, our new space is done and we think we’ve nailed it.